KALV - Kalvista Pharmaceuticals, Inc.

Name: Kalvista Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Benjamin L Palleiko	462.6K	$12.49M	-
Other	Christopher Yea	223.5K	$6.03M	-
Other	Paul K. Audhya	142.5K	$3.85M	-
Other	Nicole Sweeny	51.4K	$1.39M	-
CFO	Brian Piekos	18.1K	$490.1K	-

Activity

Buys and sells only

Transactions

10 filings · page 9

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 10, 2024	Venrock Healthcare Capital Partners III, L.P.54	10% Owner	Buy	137,700	$12.54	$1,726,456.92	+3.3%	-7.1%	-38.2%
Jan 9, 2024	Edward P. Feener72	Chief Scientific Officer	Sell10b5-1	17,321	$13.01	$225,300.44	-21.7%	-13.5%	-35.5%
Jan 4, 2024	Venrock Healthcare Capital Partners III, L.P.54	10% Owner	Buy	59,369	$12.14	$720,543.04	+1.5%	-4.0%	-23.0%
Dec 29, 2023	Venrock Healthcare Capital Partners III, L.P.54	10% Owner	Buy	519,017	$12.46	$6,465,649.95	+14.5%	-3.2%	-30.4%
Dec 27, 2023	Thomas Andrew Crockett72	CEO	Sell10b5-1	30,000	$12.02	$360,453.00	-19.0%	-7.7%	-26.7%
Nov 20, 2023	Paul K. Audhya	Chief Medical Officer	Sale+OE	7,985	$8.23	$65,710.96	-17.9%	+68.1%	+10.2%
Nov 20, 2023	Edward P. Feener72	Chief Scientific Officer	Sale+OE	4,958	$8.23	$40,800.87	-5.8%	+68.1%	+10.2%
Nov 20, 2023	Christopher Yea53	Chief Development Officer	Sale+OE	7,113	$8.23	$58,535.01	-13.4%	+68.1%	+10.2%
Nov 20, 2023	Benjamin L Palleiko46	President, CFO, Cbo & Sec'y	Sale+OE	13,008	$8.23	$107,046.73	-10.4%	+68.1%	+10.2%
Nov 20, 2023	Thomas Andrew Crockett72	CEO	Sale+OE	14,807	$8.23	$121,851.25	-8.6%	+68.1%	+10.2%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC